CTLA4 enhances the osteogenic differentiation of allogeneic human mesenchymal stem cells in a model of immune activation

Allogeneic mesenchymal stem cells (allo-MSCs) have recently garnered increasing interest for their broad clinical therapy applications. Despite this, many studies have shown that allo-MSCs are associated with a high rate of graft rejection unless immunosuppressive therapy is administered to control...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, F., Zhang, F., Sun, D., Zhang, Z.H., Dong, S.W., Xu, J.Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2015
Materias:
Biomedical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512102/
https://www.ncbi.nlm.nih.gov/pubmed/26017342
http://dx.doi.org/10.1590/1414-431X20154209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512102/
https://www.ncbi.nlm.nih.gov/pubmed/26017342
http://dx.doi.org/10.1590/1414-431X20154209

Ejemplares similares